History of Childhood/Adolescence Referral to Speciality Care or Treatment in Adult Patients with Attention-Deficit/Hyperactivity Disorder: Mutual Relations with Clinical Presentation, Psychiatric Comorbidity and Emotional Dysregulation.

attention-deficit/hyperactivity disorder comorbidity early treatment emotional dysregulation methylphenidate mood disorders

Journal

Brain sciences
ISSN: 2076-3425
Titre abrégé: Brain Sci
Pays: Switzerland
ID NLM: 101598646

Informations de publication

Date de publication:
27 Aug 2023
Historique:
received: 27 07 2023
revised: 16 08 2023
accepted: 26 08 2023
medline: 28 9 2023
pubmed: 28 9 2023
entrez: 28 9 2023
Statut: epublish

Résumé

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental condition that only rarely remits in adulthood. While several studies underlined differences between child and adult ADHD, the relationship between adult clinical presentation and early referral/treatment has been rarely investigated. In our study, 100 adults with ADHD were recruited and subdivided according to a history of referral to speciality care or treatment with methylphenidate (MPH) during childhood/adolescence. The early referral was associated with a history of disruptive behaviors during childhood/adolescence. Current ADHD symptoms were more pronounced in patients first referred during childhood/adolescence but never treated with MPH. Early MPH treatment was associated with lower rates of mood disorders and lower severity of emotional dysregulation at the time of assessment. Negative emotionality mediated the relationship between MPH treatment and mood disorders comorbidity. ADHD patients first referred during childhood/adolescence are characterized by more externalizing features than those first referred in adulthood. MPH treatment during the developmental age may have a role in preventing mood disorders in patients with ADHD, possibly by reducing emotional dysregulation.

Identifiants

pubmed: 37759852
pii: brainsci13091251
doi: 10.3390/brainsci13091251
pmc: PMC10526193
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

J Atten Disord. 2018 Jul;22(9):848-854
pubmed: 26220788
World J Psychiatry. 2023 Mar 19;13(3):84-112
pubmed: 37033892
Arch Gen Psychiatry. 2010 Nov;67(11):1168-78
pubmed: 21041618
Clin Psychol (New York). 2010 Dec 1;17(4):350-359
pubmed: 21278822
J Clin Psychiatry. 2009 Apr 21;70(5):732-40
pubmed: 19389330
Lancet Psychiatry. 2016 Dec;3(12):1157-1165
pubmed: 27745869
Atten Defic Hyperact Disord. 2013 Jun;5(2):83-92
pubmed: 23208078
Am J Psychiatry. 1998 Apr;155(4):493-8
pubmed: 9545994
J Child Adolesc Psychopharmacol. 2010 Dec;20(6):503-11
pubmed: 21186969
J Clin Psychol. 2017 Jan;73(1):99-112
pubmed: 27153511
J Clin Psychiatry. 2007 Jan;68(1):93-101
pubmed: 17284136
Clin Psychol Rev. 2014 Dec;34(8):595-607
pubmed: 25455624
J Psychiatr Res. 2016 Jan;72:6-14
pubmed: 26519764
J Am Acad Child Adolesc Psychiatry. 2017 Jul;56(7):556-569
pubmed: 28647007
J Child Adolesc Psychopharmacol. 2009 Dec;19(6):649-62
pubmed: 20035583
Medicina (Kaunas). 2021 May 12;57(5):
pubmed: 34066126
J Abnorm Psychol. 2014 May;123(2):362-374
pubmed: 24886010
Riv Psichiatr. 2021 Nov-Dec;56(6):300-307
pubmed: 34927624
J Child Adolesc Psychopharmacol. 2008 Jun;18(3):257-64
pubmed: 18582180
Eur Arch Psychiatry Clin Neurosci. 2007 Sep;257(6):309-17
pubmed: 17401730
J Atten Disord. 2011 May;15(4):295-304
pubmed: 20410322
Am J Psychiatry. 2022 Feb;179(2):142-151
pubmed: 34384227
Arch Intern Med. 2004 Jun 14;164(11):1221-6
pubmed: 15197048
J Abnorm Psychol. 2003 Aug;112(3):497-507
pubmed: 12943028
J Am Acad Child Adolesc Psychiatry. 2015 Jan;54(1):62-70.e3
pubmed: 25524791
J Affect Disord. 2013 May;147(1-3):80-6
pubmed: 23218897
J Glob Health. 2021 Feb 11;11:04009
pubmed: 33692893
Psychol Med. 2005 Feb;35(2):245-56
pubmed: 15841682
Arch Pediatr Adolesc Med. 2008 Oct;162(10):916-21
pubmed: 18838643
Addiction. 2020 Jul;115(7):1368-1377
pubmed: 31803957
Curr Psychiatry Rep. 2015 Aug;17(8):604
pubmed: 26084666
Drug Alcohol Depend. 2018 May 1;186:154-158
pubmed: 29573650
J Am Acad Child Adolesc Psychiatry. 1990 Jul;29(4):546-57
pubmed: 2387789
JAMA Psychiatry. 2016 Jul 1;73(7):655-6
pubmed: 27191055
Expert Rev Neurother. 2009 Apr;9(4):489-503
pubmed: 19344301
Psychol Med. 2006 Feb;36(2):159-65
pubmed: 16420712
J Child Psychol Psychiatry. 2010 Aug;51(8):915-23
pubmed: 20132417
Early Interv Psychiatry. 2021 Aug;15(4):957-965
pubmed: 32945134
J Atten Disord. 2019 Jan;23(2):173-180
pubmed: 25795454
J Am Acad Child Adolesc Psychiatry. 1999 Aug;38(8):966-75
pubmed: 10434488
J Adolesc Health. 2010 Mar;46(3):209-17
pubmed: 20159496
J Am Acad Child Psychiatry. 1985 Mar;24(2):211-20
pubmed: 3989165
Eur Child Adolesc Psychiatry. 2005 Feb;14(1):1-10
pubmed: 15756510
J Affect Disord. 2020 Jan 1;260:458-462
pubmed: 31539680
Riv Psichiatr. 2020 Nov-Dec;55(6):355-365
pubmed: 33349729
Prim Care Companion CNS Disord. 2014;16(3):
pubmed: 25317367
Pediatrics. 2003 Jan;111(1):179-85
pubmed: 12509574
Curr Opin Psychiatry. 2011 Jul;24(4):280-5
pubmed: 21483267
Neuropsychiatr Dis Treat. 2008 Feb;4(1):107-21
pubmed: 18728812
J Atten Disord. 2018 Apr;22(6):535-546
pubmed: 27864428
Neuropsychiatr Dis Treat. 2009;5:137-50
pubmed: 19557108
J Am Acad Child Adolesc Psychiatry. 2016 Nov;55(11):937-944.e4
pubmed: 27806861
Eur Arch Psychiatry Clin Neurosci. 2009 Mar;259(2):120-9
pubmed: 19165529
Am J Psychiatry. 2008 Jan;165(1):107-15
pubmed: 18006872
J Child Adolesc Psychopharmacol. 2018 Jun;28(5):298-305
pubmed: 29708762
Eur Psychiatry. 2019 Feb;56:14-34
pubmed: 30453134
J Child Adolesc Psychopharmacol. 2016 Mar;26(2):164-73
pubmed: 26745211
Psychopharmacol Bull. 1987;23(1):68-73
pubmed: 3602332
J Affect Disord. 2012 Dec 10;141(2-3):143-59
pubmed: 22633181
Br J Psychiatry. 2009 Mar;194(3):204-11
pubmed: 19252145
Front Psychiatry. 2021 Jul 21;12:699687
pubmed: 34366928
Br J Psychiatry. 1983 Aug;143:192-8
pubmed: 6193828
J Abnorm Child Psychol. 2002 Oct;30(5):463-75
pubmed: 12403150
Pediatrics. 2009 Jul;124(1):71-8
pubmed: 19564285
J Atten Disord. 2014 Feb;18(2):123-32
pubmed: 22740112
Psychiatry Res. 2010 May 30;177(3):299-304
pubmed: 20452063
J Affect Disord. 2021 Oct 1;293:186-196
pubmed: 34217137
Arch Gen Psychiatry. 2003 Aug;60(8):837-44
pubmed: 12912767
Arch Gen Psychiatry. 1976 Dec;33(12):1453-60
pubmed: 793563
PLoS One. 2018 Sep 26;13(9):e0204516
pubmed: 30256837
Atten Defic Hyperact Disord. 2010 Dec;2(4):267-89
pubmed: 21432612
J Affect Disord. 2019 Oct 1;257:187-194
pubmed: 31301622
Postgrad Med. 2011 Sep;123(5):50-9
pubmed: 21904086
J Affect Disord. 2005 Mar;85(1-2):53-69
pubmed: 15780676
J Atten Disord. 2009 Sep;13(2):175-87
pubmed: 19372500
Am J Psychiatry. 2006 Apr;163(4):716-23
pubmed: 16585449
Am J Psychiatry. 1993 Dec;150(12):1792-8
pubmed: 8238632
Arch Gen Psychiatry. 1981 Apr;38(4):449-56
pubmed: 7011250
J Psychiatr Res. 2017 Feb;85:49-55
pubmed: 27835739
Curr Psychiatry Rep. 2017 Nov 20;19(12):109
pubmed: 29152677
Curr Drug Abuse Rev. 2012 Sep;5(3):190-8
pubmed: 22571450
J Am Acad Child Adolesc Psychiatry. 2016 Oct;55(10):841-50
pubmed: 27663939
Arch Pediatr Adolesc Med. 2010 Oct;164(10):930-4
pubmed: 20921350

Auteurs

Giulio Emilio Brancati (GE)

Department of Clinical and Experimental Medicine, University Hospital of Pisa, 56100 Pisa, Italy.

Ugo De Rosa (U)

Department of Clinical and Experimental Medicine, University Hospital of Pisa, 56100 Pisa, Italy.

Francesco De Dominicis (F)

Mental Health Centre, Local Health Unit 2, Via San Carlo 2, 06049 Spoleto, Italy.

Alessandra Petrucci (A)

Department of Clinical and Experimental Medicine, University Hospital of Pisa, 56100 Pisa, Italy.

Alessandro Nannini (A)

Department of Clinical and Experimental Medicine, University Hospital of Pisa, 56100 Pisa, Italy.

Pierpaolo Medda (P)

Psychiatry Unit 2, Azienda Ospedaliero-Universitaria Pisana, Via Roma 67, 56126 Pisa, Italy.

Elisa Schiavi (E)

Psychiatry Unit 2, Azienda Ospedaliero-Universitaria Pisana, Via Roma 67, 56126 Pisa, Italy.

Giulio Perugi (G)

Department of Clinical and Experimental Medicine, University Hospital of Pisa, 56100 Pisa, Italy.

Classifications MeSH